Because the magnitude of CO 2 changes are not easily anticipated or estimated during assisted ventilation, Pco 2 needs to be continuously monitored to ensure proper management. During anesthesia and surgery, this is most commonly performed by continuous measurement of end-tidal (ET) Pco 2 and complemented by intermittent analysis of Pco 2 in arterial or capillary blood. The ET method is well established for use in adults and older children, 5, 6 but many of the factors that contribute to the complex respiratory physiology of the newborn and the presence of pulmonary immaturity and/or disease also impact on the accuracy of ET Pco 2 monitoring. 7 Consequently, in the neonatal intensive care unit (NICU), continuous Pco 2 is almost exclusively obtained by transcutaneous (TC) measurements. In the NICU, TC monitoring of Pco 2 is considered to be the standard of care both for absolute measurement and trend analysis, and TC readings have been found to correlate well with blood Pco 2 . [8] [9] [10] However, the use of TC Pco 2 monitoring in intraoperative care of neonates is limited, and to our knowledge, its accuracy has not been established in this population. We hypothesized that TC Pco 2 monitoring would be a relevant method in the operating room as well. To assess the accuracy of TC measurements, we compared TC Pco 2 and blood gas (BG) analyses obtained during general anesthesia in newborn infants.
METHODS
The investigation was approved of by the regional ethical review board, and in all cases, written parental consent was obtained before study inclusion. The study was not registered because patients were not assigned to treatment groups.
Subjects
We prospectively and consecutively enrolled neonates with a postconceptional age (PCA) of <44 weeks who were admitted to the NICU at Uppsala University Children's Hospital and scheduled for surgery. Enrollment was consecutive but BACKGROUND: Transcutaneous (TC) measurement of Pco 2 (TC Pco 2 ) is a well-established method to monitor assisted ventilation in neonatal intensive care, but its use in the operating room is limited, and the data regarding its performance during general anesthesia of the newborn are lacking. The aim of this study is to evaluate the performance of continuous TC Pco 2 monitoring during general anesthesia in newborn infants. METHODS: Infants (n = 25) with a gestational age of 23 to 41 weeks and a birth weight of 548 to 4114 g were prospectively enrolled. During general anesthesia and surgery, TC Pco 2 was measured continuously and recorded at 1-minute intervals. Five-minute mean values were compared with simultaneously obtained blood gas (BG) analyses of Pco 2 . Only the first paired TC and BG samples were used in this analysis. We defined precision as 2.1 times the standard deviation of the difference of the 2 samples. P < .01 was considered statistically significant. RESULTS: We obtained samples from 25 infants. The difference between TC and BG was 0.3 ± 0.7 kPa (mean ± standard deviation) giving a precision of 1.47 kPa. Nineteen of twenty-five (76%) sample pairs displayed a difference of <1 kPa (99% confidence interval, 48%-92%, P = .016). The difference in paired samples was similar for different gestational and postnatal ages and did not appear to be affected by electrocautery. CONCLUSIONS: In this small study, we did not demonstrate that TC CO 2 monitoring was accurate at P < .01. This partly reflects the small size of the study, resulting in wide 99% confidence bounds. (Anesth Analg 2016;123:1004-7)
limited by the availability of the primary investigator (V.K.). Data on each infant's gestational age, birth weight, PCA, and weight at day of study are given in Table 1 .
Transcutaneous Pco 2 Monitoring
TC partial pressure of carbon dioxide (TC Pco 2 ; kilopascal) was measured continuously by use of the TC technique using the E5280 probe (TCM 4/40, Radiometer, Denmark) with a probe temperature of 43°C according to manufacturer recommendations. Heating of the probe increases capillary blood flow as well as the diffusion of CO 2 and O 2 through the skin. Before probe placement and at 4-hour intervals, the electrode was calibrated against air and test gas. If calibration failed, the electrode membrane was replaced, and the electrode was recalibrated. The probe was placed on the upper chest, and the measurement site was changed at least every hour to minimize skin redness/thermal injury. After each probe placement, the electrode was allowed to stabilize for 15 minutes before recording TC Pco 2 values at 1-minute intervals.
Blood Gas CO 2 Analysis
BG analysis was performed using capillary blood samples (100 μL/sample) obtained from each infant's warmed foot and was immediately analyzed for Pco 2 (BG Pco 2 ; kilopascal) using an automated BG analyzer (ABL 800, Radiometer). By warming the foot, the capillary blood is considered arterialized and has been shown to correlate very well with arterial blood CO 2 in newborn infants. 11 
Measurement Procedure
In preparation for anesthesia, the TC probe was placed simultaneously with the application of electrocardiogram leads and pulse oximetry. Anesthesia was induced with thiopental (3 mg/kg), atropine (0.02 mg/kg), fentanyl (1-10 μg/kg), and neuromuscular block obtained with atracurium (0.5 mg/kg). Anesthesia was maintained with sevoflurane supplemented with intermittent dosing of fentanyl. All patients were intubated using uncuffed endotracheal tubes (2.5-3.0 mm) with pharyngeal pack and were managed using an anesthesia delivery system and ventilator (FLOW-i, Maquet, Sweden) in pressure control (infants weighing <2.8 kg) or pressure-regulated volume control mode (infants weighing >2.8 kg). Tidal volumes were set at 7 mL/kg body weight with a respiratory rate of 40-60/min and adjusted according to standard monitoring (ET Pco 2 ). Infants already on the ventilator before anesthesia were initially kept on their NICU ventilator settings.
The first blood sampling was performed after the anesthesia had been induced, the infant was intubated (including placement of a pharyngeal pack), maintained on the ventilator, and before the start of surgery. Additional blood sampling (1-2 per infant) was undertaken during the surgicy and recovery, but it was not included further in this analysis. All study data monitoring and collection were performed by the same person who had no role in taking care of the patient. The OR team was blinded to the TC Pco 2 data but it had access to the BG data.
Treatment of Data
Statistical analysis was performed using Statistical Package for Social Science, SPSS version 20 (IBM Corp, Armonk, NY). The TC Pco 2 value was calculated as the mean of the 5 TC Pco 2 values immediately before BG sampling. Limits of agreement were evaluated by the use of BlandAltman analysis. 12 The analysis was based on the difference between paired measurements of TC and BG Pco 2 (ie, TC Pco 2 − BG Pco 2 ). Bias was calculated as the average difference. Precision was calculated as the standard deviation of the difference × 2.1 (calculated as the 2-sided t-inverse statistical for P = .05 and 24 degrees of freedom × square root (1 + 1/25). Differences were assessed by Student paired t test. Data are expressed as mean ± standard deviation or median (range). A P value of <.01 was considered statistically significant. A priori, we considered an accuracy ±1 kPa to be clinically acceptable based on previously reported results from older infants during anesthesia 13, 14 and from the NICU environment. 8 The number of subjects was based on convenience. There was no power analysis before the study.
RESULTS
The analyzed data include BG and TC Pco 2 pairs from 25 infants (Figure 1 ). Bland-Altman analysis revealed a bias of 0.3 ± 0.7 kPa and a precision of ±1.47 kPa (Figure 2 ). The TC Pco 2 to BG Pco 2 difference was ≤1 kPa in 19 of 25 (76%) data pairs (99% confidence interval, 48%-92%, P = .016 versus random chance (ie, 50%).
The TC to BG Pco 2 bias (Table 2 ) and data pairs are displayed further in subgroups depending on postnatal age (<1 week or >1 week; Figure 3 ) and gestational age (preterm or term; Figure 4 ).
DISCUSSION
The present relatively small investigation does not demonstrate that TC measurements accurately reflect Pco 2 in newborn infants during general anesthesia. The precision was 1.47 kPa, less than our accepted accuracy of 1 kPa. Although the TC Pco 2 determination in 76% of the subjects was within our acceptable range of ±1 kPa of the concurrent BG Pco 2 , this did not reach statistical significance at P < .01, as demonstrated by the lower confidence bound of 48% (less than random sample).
The recognition that extremes of Pco 2 , even for brief periods of time, are associated with long-term neonatal morbidity emphasizes the need for reliable and continuous monitoring of Pco 2 during general anesthesia. Arterial BG analysis from intermittent sampling from an indwelling catheter is considered the gold standard in measuring Pco 2 . However, the dynamics of neonatal anesthetic management mandate the use of continuous measurements. Also, placing arterial lines in the tiniest infants is often painful, cumbersome, resource consuming, and it carries a risk of vascular thrombosis. 15 The most commonly applied method in anesthesia, ET CO 2 monitoring, is known to be less accurate in infants with lung disease, high respiratory rate, and small tidal volumes, 16 and it is therefore of variable value at times. TC monitoring of Pco 2 is well established in the NICU, and several studies have demonstrated a good correlation between TC and BG Pco 2 in this setting. 8 The method is independent of pulmonary disease, tidal volume, high respiratory rates, and ventilator mode (eg, small tidal volumes or high-frequency oscillatory ventilation), but it may be influenced by skin edema and hypoperfusion. Two previous studies have evaluated TC for intraoperative use in pediatric patients. 13, 18 Both studies report a good agreement between TC and BG Pco 2 , but those studies did not include any newborn infants. The authors of these studies recommend using TC as a complement to ET monitoring of Pco 2 . In a review from the study by Molloy and Deakins 19 in 2006 conclude that TC is superior to ET and promote the use of TC for noninvasive trend monitoring of Pco 2 , particularly in infants with pulmonary disease.
Arguably, management of a newborn in the NICU is distinct from that in the OR, where access to the small patient is limited by sterile draping and for the purpose of maintaining thermal stability. To measure TC Pco 2 , the electrode needs to be calibrated, heated, and repositioned at regular intervals. These procedures did not create a barrier to the performance of the measurements in our study, suggesting that TC Pco 2 monitoring requires minimal staff training.
To conclude, because of the small size of our study, we were unable to demonstrate that TC monitoring of Pco 2 in the OR was sufficiently accurate for clinical use. A larger study is required to address this question. E 
